ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500257 announcements Lupin Ltd. announcements and dividends declared BSE

Lupin Ltd. Complete list of announcements declared & dividend announcements by Lupin Ltd. 500257

Lupin Ltd. 500257 listed on BSE and deals in

Announcements and dividends declared by Lupin Ltd. 500257

Lupin shares jump 5% after strong Q1 results. Should you accumulate more?
Lupin shares jumped 5% after reporting a 52% YoY rise in Q1 FY26 net profit to Rs 1,221 crore, driven by strong US and India sales. Revenue rose to Rs 6,164 crore. While Choice Broking upgraded the stock to 'Buy' with a Rs 2,375 target, Motilal Oswal maint
Announcement as on 07 August 2025

Sun Pharma, Lupin, Dr Reddy's recall products in US market due to manufacturing issues
Three major Indian pharmaceutical companies are recalling drugs in the United States. Sun Pharma is recalling Lisdexamfetamine capsules due to failed dissolution specifications. Lupin is recalling Lisinopril and Hydrochlorothiazide tablets because of produ
Announcement as on 27 July 2025

Lupin launches generic ophthalmic medication in US
Lupin, an Indian drug firm, has introduced a generic eye medication in the US. This medication, Loteprednol Etabonate Ophthalmic Suspension, treats eye inflammation and pain. It is a bioequivalent to Bausch & Lomb's Lotemax. The drug addresses post-sur
Announcement as on 16 July 2025

Lupin signs million licensing deal with Zentiva to commercialise Certolizumab Pegol across global markets
Lupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants Zentiva commercialisation rights outside the US and Canada, primarily in Europe and CIS markets. Lupin will receive
Announcement as on 09 July 2025

Lupin launches Ipratropium Bromide nasal spray in US
Lupin Ltd has introduced Ipratropium Bromide nasal spray in the US, available in 0.03% and 0.06% strengths. These sprays, bioequivalent to Boehringer Ingelheim's Atrovent, target rhinorrhea associated with allergies, nonallergic rhinitis, and the common co
Announcement as on 04 July 2025

Announcements by Lupin Ltd. first page | Next page | Prev page |

500257 Lupin Ltd. current price & indicator signals

Moving Averages for Lupin Ltd.

  • 5Day Average: 2377.9
  • 12Day Average: 2395.2
  • 20Day Average: 2427.1
  • 50Day Average: 2373.16
  • 100Day Average: 2340.94
  • 150Day Average: 2293.42
  • 200Day Average: 2228

500257 Indicators & signals

Indicator MACD (12,26,9)

2398.6, 2404.41, 5.52
Indicator MACD is in negative zone

Indicator ADX (14)

22.78, 16.14, 25.67
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500257 Lupin Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
07 Fri Aug 2026 2360.00 2347.60 to 2416.05 -1.32% 1.4 times
06 Thu Aug 2026 2391.50 2384.20 to 2426.65 0.23% 0.45 times
05 Wed Aug 2026 2386.00 2358.95 to 2416.15 0.42% 0.93 times
04 Tue Aug 2026 2376.00 2376.00 to 2406.25 0% 0.29 times
03 Mon Aug 2026 2376.00 2361.00 to 2447.95 -1.57% 2.67 times
31 Fri Jul 2026 2413.95 2405.00 to 2433.70 -0.21% 0.74 times
30 Thu Jul 2026 2419.10 2415.00 to 2475.00 -1.25% 1.44 times
29 Wed Jul 2026 2449.80 2401.70 to 2463.00 2.3% 2.72 times
28 Tue Jul 2026 2394.70 2384.40 to 2423.90 -0.63% 0.12 times
27 Mon Jul 2026 2409.90 2371.00 to 2431.85 1.71% 0.4 times
24 Fri Jul 2026 2369.45 2340.60 to 2385.90 -1.11% 0.26 times
23 Thu Jul 2026 2396.00 2379.55 to 2428.85 -0.41% 0.47 times

Videos related to: 500257 announcements Lupin Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500257 announcements Lupin Ltd. announcements and dividends declared BSE

 

Back to top